MMED (Minimed Group) Stock Based Compensation: $21 Mil (TTM As of Jan. 2026)


MMED Minimed Group Inc MMED
15 GF Score
Price $14.28
! 1 Warning Sign
View Full Analysis

What is Minimed Group Stock Based Compensation?

Minimed Group MMED +0.14% 15 Stock Based Compensation is $21 Mil as of Jan. 2026. GuruFocus rates MMED with a GF Score™ of 15/100. The stock has 1 warning sign investors should review.

Minimed Group's Stock Based Compensation for the three months ended in Jan. 2026 was $12 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jan. 2026 was $21 Mil.

Minimed Group Stock Based Compensation Related Terms

Minimed Group Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Minimed Group's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Minimed Group Stock Based Compensation Chart

Minimed Group Annual Data
Trend Apr23 Apr24 Apr25
Stock Based Compensation
35.00 38.00 41.00

Minimed Group Quarterly Data
Apr24 Jan25 Apr25 Oct25 Jan26
Stock Based Compensation 0.00 10.00 9.00 0.00 12.00
MMED
15GF Score
Minimed Group Inc MMED
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Minimed Group Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $21 Mil.

What does a Stock Based Compensation of $21 Mil mean?
Minimed Group (MMED) has a Stock Based Compensation of $21 Mil as of Jan. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Minimed Group and its competitors.
Is Minimed Group's Stock Based Compensation too high?
Minimed Group's current Stock Based Compensation is $21 Mil. Overall, Minimed Group has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Minimed Group's Stock Based Compensation compare to ICUI and WRBY?
Minimed Group's Stock Based Compensation of $21 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Devices & Instruments company?
A good Stock Based Compensation depends on the Medical Devices & Instruments industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Minimed Group and its competitors. Minimed Group's current Stock Based Compensation is $21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Minimed Group stock overvalued right now?
Minimed Group (MMED) has a current Stock Based Compensation of $21 Mil. The current Stock Based Compensation is $21 Mil. Minimed Group's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Minimed Group (MMED), the current Stock Based Compensation is $21 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Minimed Group Business Description

Other Exchanges B8S:Germany
Address 18000 Devonshire Street, Northridge, CA, USA, 91325
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.
15GF Score

Get the complete analysis for MMED

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.28
Price